Dabur reported healthy volume-led (3% YoY) revenue performance (9% YoY – ex Badshah), driven by a sharp recovery in Healthcare business (led by Digestive and OTC) and 11% YoY revenue growth in HPC. We liked the strong volume-driven performance in oral care (8% YoY vs 2.5% category growth) in HPC.